• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Your Practice

Life Insurance and Genetic Discrimination

image_pdfFavoriteLoadingFavorite

Genetic discrimination occurs when people are treated differently by their employer or insurance company because they have a gene mutation that causes or increases the risk of an inherited disorder. Fear of discrimination is a common concern among people considering genetic testing.

Several laws at the federal and state levels help protect people against genetic discrimination. In particular, a federal law called the Genetic Information Nondiscrimination Act (GINA) is designed to protect people from this form of discrimination. However, GINA does not apply to life insurance because it is regulated by the states.

Lack of protection against genetic discrimination in obtaining life insurance has caused many individuals to defer and not undergo genetic testing. In addition, for those who receive results from genetic testing through direct-to-consumer methods, they may shy away from sharing reports with their physicians because the results could be document in their medical records. Life insurers, on the other hand, fear that consumers will obtain more coverage than what they would ordinarily obtain, although no evidence supports this conclusion. In the United States, only the state of Florida has banned life insurance companies from using genetic information, defined as the results of predictive genetic tests, in underwriting unless the information is accompanied by a diagnosis of a medical condition. This means that carriers of autosomal recessive or X-linked disorders are protected. Several other countries, including Australia, Canada, and South Korea, already restrict the use of predictive genetic test results by life insurers.

Because of the individual state regulation of life insurance in the US, it will require an initiative from insurers to self-regulate their practices regarding genetic discrimination.  If self-regulation does not mitigate discrimination, then the life insurers will need to collaborate with the other stakeholders and government to adopt a policy that adequately balances the competing economic and social arguments on both sides of the aisle.

Genetic counselors are uniquely positioned as stakeholders to shape policies. Their daily professional demands require them to stay abreast of rapidly evolving information in genetics. Laws, on the other hand, are glacially slow to change. Genetic counselors should be aware of the current and pending legislation in the states where they practice. They should also be seated at the table to help state insurance commissioners and simultaneously advocate for patients. All parties need the same information to ensure that genetic information is not misused.

References:

A survey of U. S. state insurance commissioners concerning genetic testing and life insurance: Redux at 27

Genetic testing, insurance discrimination and medical research: what the United States can learn from peer countries

Banning Genetic Discrimination in Life Insurance — Time to Follow Florida’s Lead

Political economy, stakeholder voices, and saliency: lessons from international policies regulating insurer use of genetic information

The Florida Senate: HB 1189 — Genetic Information for Insurance Purposes

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Your Practice Posts
Next >
Practice management info for your women's healthcare practice

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site